A coroner has criticised the disjointed care a 74-year-old woman received before she died at a South London hospital.
First-line treatment with TREMFYA® shows significant inhibition of radiographic progression at Week 24, which was sustained through Week 48, preserving ...
A coroner has criticised the disjointed care a 74-year-old woman received before she died at a King's College Hospital. Joan ...
Unequal global access to inflammatory bowel disease (IBD) therapies creates profound health inequities. The increasing prevalence of IBD in Western countries, driven by high incidence rates and low ...
Johnson & Johnson (JNJ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 10:40 AM ESTCompany ParticipantsCandice Long - Worldwide ...
INQUIRER.net USA on MSN
Filipino detainees describe life-threatening neglect in ICE facilities
A US Senate investigation has revealed medical neglect, unsafe food and water, and dangerous living conditions in ICE ...
The 3rd International Colorectal Surgery Conference concluded on Sunday at Raffles Dubai, in a high-level scientific event ...
Zacks Investment Research on MSN
MRK Up Nearly 10% in a Month: Should You Buy, Sell or Hold the Stock?
Merck’s MRK shares have risen 9.6% in a month. The company’s stock declined after it announced third-quarter results. Though ...
Anti-interleukins and JAK inhibitors are linked to a reduced serious infection risk among patients with ulcerative colitis.
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive top-line results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback